Intravenous (IV) Solutions Market Size to grow by USD 4,011.34 million from 2022 to 2027, Increasing prevalence of chronic diseases to boost the market growth

NEW YORK, June 7, 2023 /PRNewswire/ — The global intravenous (IV) solutions market size is estimated to increase by USD 4,011.34 million from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 7.11% during the forecast period. The increasing prevalence of chronic diseases notably drives the growth of the market. The market growth can be attributed to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. IV solutions are used to treat a variety of medical conditions and are important to deliver fluids, electrolytes, and medications to patients. Additionally, according to the International Diabetes Federation (IDF), the number of people with diabetes is expected to reach 700 million by 2045. Furthermore, diabetic patients require intravenous solutions for glucose control, and the increasing prevalence of diabetes is expected to increase the demand for intravenous solutions during the forecast period. Discover some insights on market size, historic period (2017 to 2021), and Forecast 2023-2027 before buying the full report -Request a sample report

Intravenous (IV) solutions market – Vendor Analysis
Vendor Landscape – The global intravenous (IV) solutions market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer intravenous (IV) solutions in the market are Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Group, Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., Vitapure Corp., B. Braun Melsungen AG, and Otsuka Holdings Co. Ltd. and others.

What’s New? –

• Special coverage on the Russia–Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints – Strong/Active/Niche/Trivial – Buy the report!

Vendor Offerings –

• Amanta Healthcare Ltd. – The company offers intravenous (IV) solutions under its brand SteriPort. 
• Axa Parenterals Ltd. – The company offers intravenous (IV) solutions such as dextrose injection, sodium chloride injection, Ringer lactate injection, and Dextran 40 injection with dextrose. 
• Baxter International Inc. – The company offers intravenous (IV) solutions such as Plasma-Lyte A injection and lactated Ringers injection. 
• For details on the vendor and their offerings – Request a sample report

Intravenous (IV) Solutions Market – Segmentation Assessment
Segment Overview
Technavio has segmented the market based on type (partial parenteral nutrition and total parenteral nutrition), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and geography (Asia, North America, Europe, and the Rest of the World (ROW)).

• The market share growth by the partial parenteral nutrition (PPN) segment will be significant for overall market growth during the forecast period. PPN is a type IV therapy that provides partial nutritional support to patients who cannot obtain adequate oral nutrition and is used when the patient’s gastrointestinal tract is partially functioning. However, oral intake is not sufficient to meet the body’s needs. PPN solutions typically contain combinations of glucose, electrolytes, and amino acids in varying ratios based on the patient’s specific needs. For instance, patients with liver disease may require solutions with low concentrations of amino acids, and patients with renal failure may require solutions with high concentrations of electrolytes. Hence, such factors drive segment growth during the forecast period.

Geography Overview
By geography, the global intravenous iv solutions market is segmented into Asia, North America, Europe, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global intravenous iv solutions market.

• Asia is estimated to account for 33% of the growth of the global intravenous IV solutions market during the forecast period. The rising healthcare costs, the rising prevalence of chronic diseases, and an aging population drive the regional market growth. Furthermore, factors such as the growing focus of key market players on emerging markets, increasing disposable income, the introduction of infusion therapy devices, and the increasing number of clinics and hospitals such as Fortis Healthcare (India) and Singapore General Hospital (Singapore) are also contributing to market growth. 

For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 – Download a Sample Report

Intravenous IV Solutions Market – Market Dynamics

Key Trends – 

Technological advancements in IV solutions are an emerging trend influencing the IV Solutions Market growth. IV solutions are an important part of modern medical practice because they are used to deliver medicines, fluids, and nutrients directly into the bloodstream. Their efficiency, safety, and effectiveness are improved by the latest technological advancements in IV solutions.

A recent technological advance in the IV solutions market is the development of intelligent IV pumps. Furthermore, the use of nanotechnology in IV solutions is another technological breakthrough driving the market globally. Hence, technological advances in IV solutions are expected to drive the growth of the market by improving the safety, efficacy, and efficiency of IV therapies. 

Major challenges – 

The high cost of IV solutions is impeding the Intravenous Solutions Market growth. Owing to several factors, such as the high cost of raw materials, manufacturing processes, and transportation costs, the cost is increased.

The demand for IV solutions is declining as many healthcare providers, and patients cannot afford IV solutions due to their high cost, which is especially true in developing countries where access to affordable healthcare is already limited. Hence, the high cost of IV solutions is a major challenge for the intravenous Solutions Market during the forecast period.

Drivers, Trends and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this Intravenous IV Solutions Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the intravenous IV solutions market between 2023 and 2027
• Precise estimation of the size of the intravenous IV solutions market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the intravenous IV solutions market across Asia, North America, Europe, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of intravenous IV solutions market vendors

Gain instant access to 17,000+ market research reports. 

Technavio’s SUBSCRIPTION platform

Related Reports:

The urology devices market size is expected to increase by USD 14.70 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.7%. Furthermore, this report extensively covers urology devices market segmentation by application (kidney failure treatment devices, UI management devices, BPH treatment devices, urolithiasis treatment devices, and other urology devices) and geography (North America, Europe, Asia, and Rest of the World (ROW)). The increasing prevalence of urological diseases is notably driving the urology devices market growth.

The Intravenous (IV) Fluid Monitoring Devices Market size is estimated to decline at a CAGR of 6.15% between 2022 and 2027. The size of the market is forecast to increase by USD 1,494.23 million. This intravenous (IV) fluid monitoring devices market research report extensively covers market segmentation by end-user (hospitals and clinics, ASCS, and home care), type (desktop and portable), and geography (North America, Europe, Asia, and Rest of the World (ROW)). Increasing the use of infusion therapy devices in home care settings is a key factor driving the growth of the global intravenous fluid monitoring devices market.

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global intravenous (IV) solutions market 2017 – 2021
• Exhibit 18: Historic Market Size – Data Table on global intravenous (iv) solutions market 2017 – 2021 ($ million)

• 4.2 Type Segment Analysis 2017 – 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)

• 4.3 Distribution Channel Segment Analysis 2017 – 2021
• Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments 
• Exhibit 30: Chart on Type – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type – Market share 2022-2027 (%)

• 6.2 Comparison by Type 
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type

• 6.3 Partial parenteral nutrition – Market size and forecast 2022-2027 
• Exhibit 34: Chart on Partial parenteral nutrition – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Partial parenteral nutrition – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Partial parenteral nutrition – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Partial parenteral nutrition – Year-over-year growth 2022-2027 (%)

• 6.4 Total parenteral nutrition – Market size and forecast 2022-2027 
• Exhibit 38: Chart on Total parenteral nutrition – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Total parenteral nutrition – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Total parenteral nutrition – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Total parenteral nutrition – Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Type 
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments 
• Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
• Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)

• 7.2 Comparison by Distribution Channel 
• Exhibit 46: Chart on Comparison by Distribution Channel
• Exhibit 47: Data Table on Comparison by Distribution Channel

• 7.3 Hospital pharmacy – Market size and forecast 2022-2027 
• Exhibit 48: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)

• 7.4 Retail pharmacy – Market size and forecast 2022-2027
• Exhibit 52: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)

• 7.5 Online pharmacy – Market size and forecast 2022-2027
• Exhibit 56: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Distribution Channel
• Exhibit 60: Market opportunity by Distribution Channel ($ million)
• Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 63: Chart on Market share by geography 2022-2027 (%)
• Exhibit 64: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison

• 9.3 Asia – Market size and forecast 2022-2027
• Exhibit 67: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.4 North America – Market size and forecast 2022-2027
• Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.5 Europe – Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 Germany – Market size and forecast 2022-2027
• Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.9 China – Market size and forecast 2022-2027
• Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.10 UK – Market size and forecast 2022-2027
• Exhibit 95: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.11 Canada – Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 103: Market opportunity by geography ($ million)
• Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.3 Impact of drivers and challenges 
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027

11 Vendor Landscape

• 11.2 Vendor landscape 
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 107: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 109: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 110: Matrix on vendor position and classification

• 12.3 Amanta Healthcare Ltd. 
• Exhibit 111: Amanta Healthcare Ltd. – Overview
• Exhibit 112: Amanta Healthcare Ltd. – Product / Service
• Exhibit 113: Amanta Healthcare Ltd. – Key offerings

• 12.4 Axa Parenterals Ltd. 
• Exhibit 114: Axa Parenterals Ltd. – Overview
• Exhibit 115: Axa Parenterals Ltd. – Product / Service
• Exhibit 116: Axa Parenterals Ltd. – Key offerings

• 12.5 B. Braun Melsungen AG 
• Exhibit 117: B. Braun Melsungen AG – Overview
• Exhibit 118: B. Braun Melsungen AG – Business segments
• Exhibit 119: B. Braun Melsungen AG – Key news
• Exhibit 120: B. Braun Melsungen AG – Key offerings
• Exhibit 121: B. Braun Melsungen AG – Segment focus

• 12.6 Baxter International Inc. 
• Exhibit 122: Baxter International Inc. – Overview
• Exhibit 123: Baxter International Inc. – Business segments
• Exhibit 124: Baxter International Inc. – Key news
• Exhibit 125: Baxter International Inc. – Key offerings
• Exhibit 126: Baxter International Inc. – Segment focus

• 12.7 Fresenius SE and Co. KGaA 
• Exhibit 127: Fresenius SE and Co. KGaA – Overview
• Exhibit 128: Fresenius SE and Co. KGaA – Business segments
• Exhibit 129: Fresenius SE and Co. KGaA – Key news
• Exhibit 130: Fresenius SE and Co. KGaA – Key offerings
• Exhibit 131: Fresenius SE and Co. KGaA – Segment focus

• 12.8 Grifols SA 
• Exhibit 132: Grifols SA – Overview
• Exhibit 133: Grifols SA – Business segments
• Exhibit 134: Grifols SA – Key offerings
• Exhibit 135: Grifols SA – Segment focus

• 12.9 ICU Medical Inc. 
• Exhibit 136: ICU Medical Inc. – Overview
• Exhibit 137: ICU Medical Inc. – Product / Service
• Exhibit 138: ICU Medical Inc. – Key offerings

• 12.10 JW Pharmaceutical Corp. 
• Exhibit 139: JW Pharmaceutical Corp. – Overview
• Exhibit 140: JW Pharmaceutical Corp. – Product / Service
• Exhibit 141: JW Pharmaceutical Corp. – Key offerings

• 12.11 Otsuka Holdings Co. Ltd. 
• Exhibit 142: Otsuka Holdings Co. Ltd. – Overview
• Exhibit 143: Otsuka Holdings Co. Ltd. – Business segments
• Exhibit 144: Otsuka Holdings Co. Ltd. – Key offerings
• Exhibit 145: Otsuka Holdings Co. Ltd. – Segment focus

• 12.12 Pfizer Inc. 
• Exhibit 146: Pfizer Inc. – Overview
• Exhibit 147: Pfizer Inc. – Product / Service
• Exhibit 148: Pfizer Inc. – Key news
• Exhibit 149: Pfizer Inc. – Key offerings

• 12.13 Salius Pharma Pvt. Ltd. 
• Exhibit 150: Salius Pharma Pvt. Ltd. – Overview
• Exhibit 151: Salius Pharma Pvt. Ltd. – Product / Service
• Exhibit 152: Salius Pharma Pvt. Ltd. – Key offerings

• 12.14 Sichuan Kelun Pharmaceutical Co. Ltd.
• Exhibit 153: Sichuan Kelun Pharmaceutical Co. Ltd. – Overview
• Exhibit 154: Sichuan Kelun Pharmaceutical Co. Ltd. – Product / Service
• Exhibit 155: Sichuan Kelun Pharmaceutical Co. Ltd. – Key offerings

• 12.15 Soxa Formulations and Research Pvt. Ltd.
• Exhibit 156: Soxa Formulations and Research Pvt. Ltd. – Overview
• Exhibit 157: Soxa Formulations and Research Pvt. Ltd. – Product / Service
• Exhibit 158: Soxa Formulations and Research Pvt. Ltd. – Key offerings

• 12.16 Terumo Group 
• Exhibit 159: Terumo Group – Overview
• Exhibit 160: Terumo Group – Business segments
• Exhibit 161: Terumo Group – Key news
• Exhibit 162: Terumo Group – Key offerings
• Exhibit 163: Terumo Group – Segment focus

• 12.17 Vifor Pharma Management Ltd. 
• Exhibit 164: Vifor Pharma Management Ltd. – Overview
• Exhibit 165: Vifor Pharma Management Ltd. – Product / Service
• Exhibit 166: Vifor Pharma Management Ltd. – Key news
• Exhibit 167: Vifor Pharma Management Ltd. – Key offerings

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 168: Inclusions checklist
• Exhibit 169: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 170: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 171: Research methodology
• Exhibit 172: Validation techniques employed for market sizing
• Exhibit 173: Information sources

• 13.5 List of abbreviations 
• Exhibit 174: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio